NCT03236168

Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 118 (actual)
• Sponsor: London School of Hygiene and Tropical Medicine · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

This is a pilot study evaluating if treatment for scabies also treats headlice in the same community

Detailed description

Background: Scabies and head lice are both ubiquitous ectoparasitic infections that have been identified as common public health problems in the Pacific Island Country Territories. Mass drug administration using ivermectin is increasingly recognised as an effective strategy for scabies treatment and control, however, its possible impact on prevalence of head lice has not been evaluated. Given that oral ivermectin is an effective treatment option for pediculosis capitis, we hypothesise that community treatment with ivermectin for scabies would also provide benefit by reducing prevalence of head lice infestation in the community. We aim to test this hypothesis with a small-scale pilot study in the Solomon Islands. Methodology: The study would be carried out at the Atoifi Adventist Hospital campus, on the North-Eastern coast of the island of Malaita. The campus houses an estimated 180 individuals and all residents would be invited to participate in the study and be offered treatment. At baseline all individuals would undergo a standardized examination to collect data on the presence of scabies, impetigo and head lice. Following examination individuals would be weighed and given directly observed standard treatment for scabies. Treatment for scabies consists of one oral dose of ivermectin (200 micrograms per kilogram) at day 1 and at day 8. Individuals with contra-indications (pregnancy, breast feeding, weight under 15kg) would be offered the alternative of 5% permethrin cream and malathion shampoo. Individuals would be re-examined at 48hours (to assess immediate killing of head lice) and again at 2 weeks. Final follow-up will be at 3 months to establish: 1) whether changes in head lice prevalence have been sustained 2) what the impact of treatment on scabies and impetigo with ivermectin is in this specific community.

Conditions

• Scabies
• Head Lice

Interventions

Type	Name	Description
DRUG	Ivermectin	A single weight based dose of ivermectin
DRUG	Permethrin 5%	Permethrin cream is used in conjunction with Malathion shampoo when ivermectin is contra-indicated
DRUG	Malathion Shampoo 0.5%	Permethrin cream is used in conjunction with Malathion shampoo when ivermectin is contra-indicated

Timeline

• Start date: 2017-08-01
• Primary completion: 2017-12-31
• Completion: 2018-02-28
• First posted: 2017-08-01
• Last updated: 2019-06-14
• Results posted: 2019-06-14

Locations

1 site across 1 country: Solomon Islands